RESEARCH研究

2018 研究業績・論文発表

論文

Kuwahara M, Suzuki H, Oka N, Ogata H, Yanagimoto S, Sadakane S, Fukumoto Y, Yamana M, Yuhara Y, Yoshikawa K, Morikawa M, Kawai S, Okazaki M, Tsujimoto T, Kira JI, Kusunoki S.

Electron microscopic abnormality and therapeutic efficacy in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin155 immunoglobulin G4 antibody.

Muscle Nerve 2018; 57: 498-502

Yamagishi Y, Saigoh K, Saito Y, Ogawa I, Mitsui Y, Hamada Y, Samukawa M, Suzuki H, Kuwahara M, Hirano M, Noguchi N, Kusunoki S.

Diagnosis of Parkinson's disease and the level of oxidized DJ-1 protein.

Neurosci Res.128;58-62

Fukumoto Y, Kuwahara M, Kawai S, Nakahama K, Kusunoki S.

Acute demyelinating polyneuropathy induced by nivolumab.

J Neurol Neurosurg Psychiatry. 2018; 89: 435-437

Chong PF, Kira R, Mori H, Okumura A, Torisu H, Yasumoto S, Shimizu H, Fujimoto T, Hanaoka N, Kusunoki S, Takahashi T, Oishi K, Tanaka-Taya K. AFM collaborative study investigators.

Clinical Features of Acute Flaccid Myelitis Temporally Associated with an Enterovirus D68 Outbreak: Results of a Nationwide Survey of Acute Flaccid Paralysis in Japan, August-December 2015.

Clin Infect Dis 2018; 66: 653-664

Miyamoto K, Fujihara K, Kira JI, Kuriyama N, Matsui M, Tamakoshi A, Kusunoki S.

Nationwide epidemiological study of neuromyelitis optica in Japan.

J Neurol Neurosurg Psychiatry 2018; 89: 667-668.

Matsui N, Nodera H, Kuzume D, Iwasa N, Unai Y, Sakai W, Miyazaki Y, Yamazaki H, Osaki Y, Furukawa T, Yamasaki M, Izumi Y, Kusunoki S, Arisawa K, Kaji R.

Guillain-Barré syndrome in a local area in Japan, 2006-2015: An epidemiological and clinical study of 108 patients.

Eur J Neurol 2018 25:718-724.

Ueki S, Nakamura M, Sasaki R, Okada Y, Yoshikawa K, Kusunoki S, Ishii K, Kusaka H, Kondo T.

Beneficial effect of Bendamustine in a patient with anti-MAG/SGPG neuropathy and Bing-Neel syndrome associated with Waldenström macroglobulinemia: a case report. Case Rep

Neurol 2018; 10: 88-94

Kuwabara S, Misawa S, Mori M, Iwai Y, Ochi K, Suzuki H, Nodera H, Tamaoka A, Iijima M, Toda T, Yoshikawa H, Kanda T, Sakamoto K, Kusunoki S, Sobue G, Kaji R; Glovenin-I MMN Study Group.

Intravenous immunoglobulin for maintenance treatment of multifocal motor neuropathy: a multicenter, open-label, 52-week phase 3 trial.

J Peripher Nerv Syst doi: 10.1111/jns.12268. [Epub ahead of print]

Misawa S, Kuwabara S, Sato Y, Yamaguchi N, Nagashima K, Katayama K, Sekiguchi Y, Iwai Y, Amino H, Suichi T, Yokota T, Nishida Y, Kanouchi T, Kohara N, Kawamoto M, Ishii J, Kuwahara M, Suzuki H, Hirata K, Kokubun N, Masuda R, Kaneko J, Yabe I, Sasaki H, Kaida KI, Takazaki H, Suzuki N, Suzuki S, Nodera H, Matsui N, Tsuji S, Koike H, Yamasaki R, Kusunoki S; Japanese Eculizumab Trial for GBS (JET-GBS) Study Group.

Safety and efficacy of eculizumab in Guillain-Barré syndrome: a multicentre, double-blind, randomised phase 2 trial.

Lancet Neurol. 2018 17(6):519-529 pii: S1474-4422(18)30114-5.

Yamashita K, Kinoshita M, Miyamoto K, Namba A, Shimizu M, Koda T, Sugimoto T, Mori Y, Yoshioka Y, Nakatsuji Y, Kumanogoh A, Kusunoki S, Mochizuki H, Okuno T.

Cerebrospinal fluid mitochondrial DNA in neuromyelitis optica spectrum disorder.

J Neuroinflammation. 2018 Apr 27; 15:125.

Samukawa M, Hirano M, Saigoh K, Kawai S, Hamada Y, Takahashi D, Nakamura Y, Kusunoki S.

PSP-Phenotype in SCA8: Case Report and Systemic Review.

Cerebellum. 2018 Jun 19.

Inoue K, Fujimura H, Toyooka K, Hirano M, Nakamura Y, Sakoda S.

An autopsy case of familial amyotrophic lateral sclerosis and dementia with p.R487H VCP gene mutation.

Cogent Med. 2018;5:1434925.

Hirano M, Samukawa M, Isono C, Saigoh K, Nakamura Y, Kusunoki S.

Noncoding repeat expansions for ALS in Japan are associated with the ATXN8OS gene.

Neurol Genet. 2018 4:e252.

Moriguchi K, Miyamoto K, Fukumoto Y, Kusunoki S.

4-Aminopyridine ameliorates relapsing remitting experimental autoimmune encephalomyelitis in SJL/J mice.

J Neuroimmunol. 2018; 323:131-135.

Yoshikawa K, Kuwahara M, Morikawa M, Fukumoto Y, Yamana M, Yamagishi Y, Kusunoki S.

Varied antibody reactivities and clinical relevance in anti-GQ1b antibody-related diseases.

Neurol Neuroimmunol Neuroinflamm 2018; 5: e501.

Doets AY, Verboon C, van den Berg B, Harbo T, Cornblath DR, Willison HJ, Islam Z, Attarian S, Barroso FA, Bateman K, Benedetti L, van den Bergh P, Casasnovas C, Cavaletti G, Chavada G, Claeys KG, Dardiotis E, Davidson A, van Doorn PA, Feasby TE, Galassi G, Gorson KC, Hartung HP, Hsieh ST, Hughes RAC, Illa I, Islam B, Kusunoki S, Kuwabara S, Lehmann HC, Miller JAL, Mohammad QD, Monges S, Nobile Orazio E, Pardo J, Pereon Y, Rinaldi S, Querol L, Reddel SW, Reisin RC, Shahrizaila N, Sindrup SH, Waqar W, Jacobs BC; IGOS Consortium .

Regional variation of Guillain-Barré syndrome.

Brain. 2018; 141: 2866-2877.